Bill
Bill > HB2421
PA HB2421
Providing for research and clinical studies of psilocybin and psilocybin-assisted therapy.
summary
Introduced
03/16/2022
03/16/2022
In Committee
03/16/2022
03/16/2022
Crossed Over
Passed
Dead
11/30/2022
11/30/2022
Introduced Session
2021-2022 Regular Session
Bill Summary
Providing for research and clinical studies of psilocybin and psilocybin-assisted therapy.
AI Summary
This bill provides for research and clinical studies of psilocybin and psilocybin-assisted therapy in Pennsylvania. The Department of Health, in collaboration with the Health Research Advisory Committee, will contract with academic research institutions to study the efficacy and cost-benefit optimization of psilocybin and psilocybin-assisted therapy in treating various mental health conditions and traumatic brain injury. The bill requires the Department to issue interim and final reports on the research findings, current laws and regulations, and recommendations for a framework to further research and implement psilocybin-assisted therapy in the state.
Committee Categories
Health and Social Services
Sponsors (9)
Tracy Pennycuick (R)*,
Jenn O'Mara (D),
Tim O'Neal (R),
Greg Rothman (R),
David Rowe (R),
Mark Rozzi (D),
Frank Ryan (R),
Lynda Schlegel-Culver (R),
Mike Schlossberg (D),
Last Action
Referred to HEALTH (on 03/16/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...